KRYS Krystal Biotech
$326.81 -2.40%
US Stock · Health Care
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Hover to inspect. EOD data.
1D
-2.40%
YTD
+78.60%
P/E
39.56
P/B
5.86
ROE
19.3%
Div yield
—
Beta
0.76
Market cap
$9.6B
RSI (14)
42
Next earnings
Nov 2, 2026
Previous session
close of Oct 6, 2026 · EOD, no live order bookOpen
$335.16
Close
$326.81
VWAP (n/a)
—
Day high
$335.16
Day low
$319.61
Volume
352K
VWAP = daily turnover ÷ volume — the volume-weighted average, the closest EOD read on where trading actually clustered. A true order book is live-only and needs a broker feed. Turnover/VWAP available for MOEX listings.
Latest headlines
Krystal Biotech (KRYS) Has a Blockbuster Rare-Disease Drug. Is Its Moat Durable?
Yahoo Finance · Oct 6
Krystal Stock Gains 13.4% in a Month: What Is Driving the Rally?
Yahoo Finance · Sep 3
Krystal Biotech to Present at 2026 Cantor Global Healthcare Conference
Yahoo Finance · Sep 3
Krystal Biotech (KRYS) Up 12% Since Last Earnings Report: Can It Continue?
Yahoo Finance · Sep 2
Krystal Biotech Seen Positioned for Further Gains on Vyjuvek, Pipeline Readouts, RBC Says
Yahoo Finance · Aug 14
Here Are Friday’s Top Wall Street Analyst Research Calls: Cinemark, Digital Realty, Fox Corporation, Krystal Biotech, LTC Properties, Roku, Sandisk, T-Mobile US, Wayfair, and More
Yahoo Finance · Aug 14
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
8-K Aug 3, 2026 View → 10-Q Aug 3, 2026 View → 8-K Jul 21, 2026 View → 8-K May 20, 2026 View → 8-K May 4, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell KRYS. Try it in the Lab to size a position and see the risk.